Product
TNX-103
1 clinical trial
1 indication
Indication
Pulmonary HypertensionClinical trial
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients With Heart Failure With Preserved Left Ventricular Ejection Fraction (PH-HFpEF)Status: Recruiting, Estimated PCD: 2027-03-01